Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NCT06672081Recruiting
- Sponsor
- Leipzig Heart Science
- Start
- Dec 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in pulmonary embolism (PE) (2 arms), sponsored by Leipzig Heart Science. Primary endpoint: Composite endpoint of mortality (all-cause) and recurrent cardiac arrest or persistent / recurrent shock at 7 days. Started Dec 2024; status: recruiting.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT06672081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06672081.